| 000 | 01659 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517052511.0 | ||
| 264 | 0 | _c20180129 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1477-0970 | ||
| 024 | 7 |
_a10.1177/1352458515604384 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSimula, Sakari | |
| 245 | 0 | 0 |
_aEffect of fingolimod on cardiac autonomic regulation in patients with multiple sclerosis. _h[electronic resource] |
| 260 |
_bMultiple sclerosis (Houndmills, Basingstoke, England) _c07 2016 |
||
| 300 |
_a1080-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aElectrocardiography, Ambulatory |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFingolimod Hydrochloride _xtherapeutic use |
| 650 | 0 | 4 |
_aHeart _xinnervation |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdiagnosis |
| 650 | 0 | 4 |
_aParasympathetic Nervous System _xdrug effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 |
_aSympathetic Nervous System _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLaitinen, Tomi | |
| 700 | 1 | _aLaitinen, Tiina M | |
| 700 | 1 | _aTarkiainen, Tuula | |
| 700 | 1 | _aHartikainen, Päivi | |
| 700 | 1 | _aHartikainen, Juha Ek | |
| 773 | 0 |
_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 22 _gno. 8 _gp. 1080-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1352458515604384 _zAvailable from publisher's website |
| 999 |
_c25254382 _d25254382 |
||